Novartis, Seattle Genetics, Celgene Reveal Latest News on Blood Disease Drugs
At the 52nd annual meeting of the American Society of Hematology, which wraps up Tuesday, Novartis, Celgene and Seattle Genetics revealed the latest news from their studies on blood diseases and cancers. But despite some positi…